Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Assets Average (2016 - 2023)

Historic Assets Average for Aptevo Therapeutics (APVO) over the last 8 years, with Q3 2023 value amounting to $28.0 million.

  • Aptevo Therapeutics' Assets Average fell 2050.25% to $28.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $28.0 million, marking a year-over-year decrease of 2050.25%. This contributed to the annual value of $45.4 million for FY2022, which is 1755.09% down from last year.
  • Latest data reveals that Aptevo Therapeutics reported Assets Average of $28.0 million as of Q3 2023, which was down 2050.25% from $31.9 million recorded in Q2 2023.
  • In the past 5 years, Aptevo Therapeutics' Assets Average ranged from a high of $74.2 million in Q1 2019 and a low of $21.9 million during Q2 2020
  • In the last 5 years, Aptevo Therapeutics' Assets Average had a median value of $45.5 million in 2020 and averaged $48.3 million.
  • As far as peak fluctuations go, Aptevo Therapeutics' Assets Average crashed by 7022.96% in 2020, and later skyrocketed by 22049.69% in 2021.
  • Quarter analysis of 5 years shows Aptevo Therapeutics' Assets Average stood at $57.0 million in 2019, then dropped by 20.18% to $45.5 million in 2020, then surged by 32.58% to $60.3 million in 2021, then plummeted by 45.35% to $33.0 million in 2022, then decreased by 14.97% to $28.0 million in 2023.
  • Its last three reported values are $28.0 million in Q3 2023, $31.9 million for Q2 2023, and $34.6 million during Q1 2023.